社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
DZL
IP属地：未知
+关注
帖子 · 368
帖子 · 368
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
DZL
DZL
·
2021-12-21
Nio, Fastly, Cresco Labs, Teladoc Health, Pinterest returning for more gains in 2022
非常抱歉，此主贴已删除
看
5,376
回复
2
点赞
1
编组 21备份 2
分享
举报
DZL
DZL
·
2021-12-21
Microsoft expanding into global digital media with acquisition of Xandr
非常抱歉，此主贴已删除
看
5,994
回复
1
点赞
1
编组 21备份 2
分享
举报
DZL
DZL
·
2021-12-20
Novavax boosting its way up against Omicron
Novavax Climbs as Its Covid Vaccine Recommended for EU Approval<blockquote>Novavax 的 Covid 疫苗建议欧盟批准，股价上涨</blockquote>
Novavax shares rose 5% in early trading.The European Union's drug regulator on Monday approved use o
Novavax Climbs as Its Covid Vaccine Recommended for EU Approval<blockquote>Novavax 的 Covid 疫苗建议欧盟批准，股价上涨</blockquote>
看
4,251
回复
2
点赞
1
编组 21备份 2
分享
举报
DZL
DZL
·
2021-12-19
Nvidia, Tesla, Snowflake, Unity Software, UiPath, the 5 tech growth stock into 2022
非常抱歉，此主贴已删除
看
3,701
回复
2
点赞
8
编组 21备份 2
分享
举报
DZL
DZL
·
2021-12-19
Nvidia, ASML Holding, Amazon, the potential3 growth beyond Apple by 2035
非常抱歉，此主贴已删除
看
6,053
回复
评论
点赞
5
编组 21备份 2
分享
举报
DZL
DZL
·
2021-12-19
Coca-Cola, the add call with growing EPS inlong term
非常抱歉，此主贴已删除
看
4,457
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
DZL
DZL
·
2021-12-18
Valuation of vaccine makers dipped with uncertainty of pandemic
Why Pfizer and Johnson & Johnson Fell on Friday<blockquote>为什么辉瑞和强生公司周五下跌</blockquote>
What happened Two prominent U.S. coronavirus stocks ended the week on a down note. Pfizer and Johnso
Why Pfizer and Johnson & Johnson Fell on Friday<blockquote>为什么辉瑞和强生公司周五下跌</blockquote>
看
4,992
回复
1
点赞
2
编组 21备份 2
分享
举报
DZL
DZL
·
2021-12-17
Bank of America, American Express, U.S. Bancorp - Buffett’s stronghold with national pride
非常抱歉，此主贴已删除
看
5,120
回复
评论
点赞
9
编组 21备份 2
分享
举报
DZL
DZL
·
2021-12-17
Palantir and SEMrush, for those who unlock long term potential
非常抱歉，此主贴已删除
看
3,538
回复
1
点赞
4
编组 21备份 2
分享
举报
DZL
DZL
·
2021-12-17
Microsoft, Veeva Systems, Palo Alto Networks, tech and cloud the proven haven during correction
非常抱歉，此主贴已删除
看
5,798
回复
1
点赞
5
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3582006183410147","uuid":"3582006183410147","gmtCreate":1618918081496,"gmtModify":1637858055627,"name":"DZL","pinyin":"dzl","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/640ac3ae648fded99146300a53c24a5b","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":56,"headSize":302,"tweetSize":368,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.04.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102,"isScarce":0,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.21%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":691020872,"gmtCreate":1640099544528,"gmtModify":1640099545142,"author":{"id":"3582006183410147","authorId":"3582006183410147","name":"DZL","avatar":"https://static.tigerbbs.com/640ac3ae648fded99146300a53c24a5b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582006183410147","authorIdStr":"3582006183410147"},"themes":[],"title":"","htmlText":"Nio, Fastly, Cresco Labs, Teladoc Health, Pinterest returning for more gains in 2022","listText":"Nio, Fastly, Cresco Labs, Teladoc Health, Pinterest returning for more gains in 2022","text":"Nio, Fastly, Cresco Labs, Teladoc Health, Pinterest returning for more gains in 2022","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/691020872","repostId":"2193156023","repostType":4,"isVote":1,"tweetType":1,"viewCount":5376,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691064885,"gmtCreate":1640099362558,"gmtModify":1640100459773,"author":{"id":"3582006183410147","authorId":"3582006183410147","name":"DZL","avatar":"https://static.tigerbbs.com/640ac3ae648fded99146300a53c24a5b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582006183410147","authorIdStr":"3582006183410147"},"themes":[],"title":"","htmlText":"Microsoft expanding into global digital media with acquisition of Xandr","listText":"Microsoft expanding into global digital media with acquisition of Xandr","text":"Microsoft expanding into global digital media with acquisition of Xandr","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/691064885","repostId":"2193615778","repostType":4,"isVote":1,"tweetType":1,"viewCount":5994,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693667584,"gmtCreate":1640014824261,"gmtModify":1640014824881,"author":{"id":"3582006183410147","authorId":"3582006183410147","name":"DZL","avatar":"https://static.tigerbbs.com/640ac3ae648fded99146300a53c24a5b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582006183410147","authorIdStr":"3582006183410147"},"themes":[],"title":"","htmlText":"Novavax boosting its way up against Omicron","listText":"Novavax boosting its way up against Omicron","text":"Novavax boosting its way up against Omicron","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/693667584","repostId":"1100495818","repostType":4,"repost":{"id":"1100495818","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640010925,"share":"https://www.laohunote.com/m/news/1100495818?lang=zh_CN&edition=full","pubTime":"2021-12-20 22:35","market":"us","language":"en","title":"Novavax Climbs as Its Covid Vaccine Recommended for EU Approval<blockquote>Novavax 的 Covid 疫苗建议欧盟批准，股价上涨</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1100495818","media":"Tiger Newspress","summary":"Novavax shares rose 5% in early trading.The European Union's drug regulator on Monday approved use o","content":"<p>Novavax shares rose 5% in early trading.<img src=\"https://static.tigerbbs.com/2b0834cd3440742caa0135d7d6be7ec2\" tg-width=\"708\" tg-height=\"595\" width=\"100%\" height=\"auto\">The European Union's drug regulator on Monday approved use of the COVID-19 vaccine from U.S.-based Novavax in people 18 years and older, paving the way for a fifth coronavirus shot in the region as the Omicron coronavirus variant spreads.</p><p><blockquote>Novavax 股价早盘上涨 5%。欧盟药品监管机构周一批准在 18 岁及以上人群中使用美国 Novavax 公司的 COVID-19 疫苗，随着奥密克戎冠状病毒变种的传播，为该地区第五次冠状病毒注射铺平了道路。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax Climbs as Its Covid Vaccine Recommended for EU Approval<blockquote>Novavax 的 Covid 疫苗建议欧盟批准，股价上涨</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax Climbs as Its Covid Vaccine Recommended for EU Approval<blockquote>Novavax 的 Covid 疫苗建议欧盟批准，股价上涨</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-20 22:35</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Novavax shares rose 5% in early trading.<img src=\"https://static.tigerbbs.com/2b0834cd3440742caa0135d7d6be7ec2\" tg-width=\"708\" tg-height=\"595\" width=\"100%\" height=\"auto\">The European Union's drug regulator on Monday approved use of the COVID-19 vaccine from U.S.-based Novavax in people 18 years and older, paving the way for a fifth coronavirus shot in the region as the Omicron coronavirus variant spreads.</p><p><blockquote>Novavax 股价早盘上涨 5%。欧盟药品监管机构周一批准在 18 岁及以上人群中使用美国 Novavax 公司的 COVID-19 疫苗，随着奥密克戎冠状病毒变种的传播，为该地区第五次冠状病毒注射铺平了道路。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1100495818","content_text":"Novavax shares rose 5% in early trading.The European Union's drug regulator on Monday approved use of the COVID-19 vaccine from U.S.-based Novavax in people 18 years and older, paving the way for a fifth coronavirus shot in the region as the Omicron coronavirus variant spreads.","news_type":1,"symbols_score_info":{"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":4251,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693036534,"gmtCreate":1639924405605,"gmtModify":1639924406144,"author":{"id":"3582006183410147","authorId":"3582006183410147","name":"DZL","avatar":"https://static.tigerbbs.com/640ac3ae648fded99146300a53c24a5b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582006183410147","authorIdStr":"3582006183410147"},"themes":[],"title":"","htmlText":"Nvidia, Tesla, Snowflake, Unity Software, UiPath, the 5 tech growth stock into 2022","listText":"Nvidia, Tesla, Snowflake, Unity Software, UiPath, the 5 tech growth stock into 2022","text":"Nvidia, Tesla, Snowflake, Unity Software, UiPath, the 5 tech growth stock into 2022","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/693036534","repostId":"2192903795","repostType":4,"isVote":1,"tweetType":1,"viewCount":3701,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693031441,"gmtCreate":1639924004153,"gmtModify":1639924004723,"author":{"id":"3582006183410147","authorId":"3582006183410147","name":"DZL","avatar":"https://static.tigerbbs.com/640ac3ae648fded99146300a53c24a5b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582006183410147","authorIdStr":"3582006183410147"},"themes":[],"title":"","htmlText":"Nvidia, ASML Holding, Amazon, the potential3 growth beyond Apple by 2035","listText":"Nvidia, ASML Holding, Amazon, the potential3 growth beyond Apple by 2035","text":"Nvidia, ASML Holding, Amazon, the potential3 growth beyond Apple by 2035","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693031441","repostId":"2192035909","repostType":4,"isVote":1,"tweetType":1,"viewCount":6053,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693033775,"gmtCreate":1639923890057,"gmtModify":1639934501243,"author":{"id":"3582006183410147","authorId":"3582006183410147","name":"DZL","avatar":"https://static.tigerbbs.com/640ac3ae648fded99146300a53c24a5b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582006183410147","authorIdStr":"3582006183410147"},"themes":[],"title":"","htmlText":"Coca-Cola, the add call with growing EPS inlong term","listText":"Coca-Cola, the add call with growing EPS inlong term","text":"Coca-Cola, the add call with growing EPS inlong term","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693033775","repostId":"2192890991","repostType":4,"isVote":1,"tweetType":1,"viewCount":4457,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699505515,"gmtCreate":1639830070081,"gmtModify":1639830070633,"author":{"id":"3582006183410147","authorId":"3582006183410147","name":"DZL","avatar":"https://static.tigerbbs.com/640ac3ae648fded99146300a53c24a5b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582006183410147","authorIdStr":"3582006183410147"},"themes":[],"title":"","htmlText":"Valuation of vaccine makers dipped with uncertainty of pandemic ","listText":"Valuation of vaccine makers dipped with uncertainty of pandemic ","text":"Valuation of vaccine makers dipped with uncertainty of pandemic","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/699505515","repostId":"1109831591","repostType":4,"repost":{"id":"1109831591","kind":"news","pubTimestamp":1639804463,"share":"https://www.laohunote.com/m/news/1109831591?lang=zh_CN&edition=full","pubTime":"2021-12-18 13:14","market":"us","language":"en","title":"Why Pfizer and Johnson & Johnson Fell on Friday<blockquote>为什么辉瑞和强生公司周五下跌</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1109831591","media":"Motley Fool","summary":"What happened\nTwo prominent U.S. coronavirus stocks ended the week on a down note. Pfizer and Johnso","content":"<p>What happened</p><p><blockquote>发生了什么事</blockquote></p><p> Two prominent U.S. coronavirus stocks ended the week on a down note. <a href=\"https://laohu8.com/S/PFE\"><b>Pfizer</b></a> and <a href=\"https://laohu8.com/S/JNJ\"><b>Johnson & Johnson</b></a> both fell on the day by nearly 3%. This followed a prominent investment bank's rather lukewarm take on their current prospects.</p><p><blockquote>两只著名的美国冠状病毒股票本周收盘下跌。<a href=\"https://laohu8.com/S/PFE\"><b>辉瑞</b></a>和<a href=\"https://laohu8.com/S/JNJ\"><b>强生公司</b></a>两者当天均下跌近3%。此前，一家著名投资银行对其当前前景持相当冷淡的态度。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/c6a2f152eebbe10f5ab65a99815f461c\" tg-width=\"975\" tg-height=\"637\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> So what</p><p><blockquote>那又怎样</blockquote></p><p> <b>Goldman Sachs</b> analyst Chris Shibutani initiated coverage on Pfizer and Johnson & Johnson on Friday, tagging both high-profile healthcare industry stocks with neutral recommendations.</p><p><blockquote><b>高盛</b>分析师 Chris Shibutani 周五开始对辉瑞和强生进行报道，对这两只备受瞩目的医疗保健行业股票给予中性建议。</blockquote></p><p> Shibutani is concerned with what he considers to be Pfizer's somewhat cloudy future, despite the great success of the Comirnaty coronavirus vaccine it developed with Germanbiotech <b>BioNTech</b>.</p><p><blockquote>尽管辉瑞与德国生物技术公司合作开发的 Comirnaty 冠状病毒疫苗取得了巨大成功，但涩谷仍对他认为辉瑞有些模糊的未来感到担忧<b>生物技术</b>.</blockquote></p><p> \"Our views on [Pfizer] come down to that we estimate around one-third of its current valuation is attributed to the COVID-19 vaccine and therapeutic [products], and we feel the trajectory for both remains highly uncertain,\" he wrote.</p><p><blockquote>他写道：“我们对辉瑞的看法是，我们估计其当前估值的三分之一左右归因于 COVID-19 疫苗和治疗产品，我们认为两者的发展轨迹仍然高度不确定。”</blockquote></p><p> As for Johnson & Johnson, the prognosticator feels the stock is also fairly valued. However, he sounded a more optimistic note about the company's potential.</p><p><blockquote>至于强生公司，预测者认为该股的估值也相当合理。然而，他对该公司的潜力表示了更乐观的态度。</blockquote></p><p> \"With [Johnson & Johnson] in the midst of transitions across several domains for the organization ... we see possibilities -- even within an organization of [Johnson & Johnson]'s scale and scope -- for additional potentially disruptive opportunities to develop that could reshape the investment thesis, in our view,\" he wrote.</p><p><blockquote>“随着 [强生] 正在组织的多个领域进行转型……我们看到了可能性——即使在 [强生] 规模和范围的组织内——额外的潜在颠覆性发展机会的可能性，我们认为，这可能会重塑投资论点，”他写道。</blockquote></p><p> Last month, Johnson & Johnson announced plans to spin off its sprawlingconsumer healthcare division.</p><p><blockquote>上个月，强生公司宣布计划剥离其庞大的消费者医疗保健部门。</blockquote></p><p> Shibutani's price target on Pfizer stock is $51 per share, and that for Johnson & Johnson is $161.</p><p><blockquote>涩谷对辉瑞股票的目标价为每股 51 美元，强生公司的目标价为每股 161 美元。</blockquote></p><p> Now what</p><p><blockquote>现在呢</blockquote></p><p> Pfizer and Johnson & Johnson are certainly heading into some uncertain waters -- both with the coronavirus and, in the latter company's case, the apparently looming spinoff. To my mind, though, the two companies have plenty of strength in numerous product areas outside of their respective vaccines, so investors shouldn't be too discouraged by Goldman Sachs' latest evaluations.</p><p><blockquote>辉瑞（Pfizer）和强生公司（Johnson & Johnson）无疑正进入一些不确定的水域——无论是冠状病毒，还是后者显然迫在眉睫的分拆。不过，在我看来，两家公司在各自疫苗之外的众多产品领域都拥有足够的实力，因此投资者不应对高盛的最新评估感到太气馁。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Pfizer and Johnson & Johnson Fell on Friday<blockquote>为什么辉瑞和强生公司周五下跌</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Pfizer and Johnson & Johnson Fell on Friday<blockquote>为什么辉瑞和强生公司周五下跌</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool</strong><span class=\"h-time small\">2021-12-18 13:14</span>\n</p>\n</h4>\n</header>\n<article>\n<p>What happened</p><p><blockquote>发生了什么事</blockquote></p><p> Two prominent U.S. coronavirus stocks ended the week on a down note. <a href=\"https://laohu8.com/S/PFE\"><b>Pfizer</b></a> and <a href=\"https://laohu8.com/S/JNJ\"><b>Johnson & Johnson</b></a> both fell on the day by nearly 3%. This followed a prominent investment bank's rather lukewarm take on their current prospects.</p><p><blockquote>两只著名的美国冠状病毒股票本周收盘下跌。<a href=\"https://laohu8.com/S/PFE\"><b>辉瑞</b></a>和<a href=\"https://laohu8.com/S/JNJ\"><b>强生公司</b></a>两者当天均下跌近3%。此前，一家著名投资银行对其当前前景持相当冷淡的态度。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/c6a2f152eebbe10f5ab65a99815f461c\" tg-width=\"975\" tg-height=\"637\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> So what</p><p><blockquote>那又怎样</blockquote></p><p> <b>Goldman Sachs</b> analyst Chris Shibutani initiated coverage on Pfizer and Johnson & Johnson on Friday, tagging both high-profile healthcare industry stocks with neutral recommendations.</p><p><blockquote><b>高盛</b>分析师 Chris Shibutani 周五开始对辉瑞和强生进行报道，对这两只备受瞩目的医疗保健行业股票给予中性建议。</blockquote></p><p> Shibutani is concerned with what he considers to be Pfizer's somewhat cloudy future, despite the great success of the Comirnaty coronavirus vaccine it developed with Germanbiotech <b>BioNTech</b>.</p><p><blockquote>尽管辉瑞与德国生物技术公司合作开发的 Comirnaty 冠状病毒疫苗取得了巨大成功，但涩谷仍对他认为辉瑞有些模糊的未来感到担忧<b>生物技术</b>.</blockquote></p><p> \"Our views on [Pfizer] come down to that we estimate around one-third of its current valuation is attributed to the COVID-19 vaccine and therapeutic [products], and we feel the trajectory for both remains highly uncertain,\" he wrote.</p><p><blockquote>他写道：“我们对辉瑞的看法是，我们估计其当前估值的三分之一左右归因于 COVID-19 疫苗和治疗产品，我们认为两者的发展轨迹仍然高度不确定。”</blockquote></p><p> As for Johnson & Johnson, the prognosticator feels the stock is also fairly valued. However, he sounded a more optimistic note about the company's potential.</p><p><blockquote>至于强生公司，预测者认为该股的估值也相当合理。然而，他对该公司的潜力表示了更乐观的态度。</blockquote></p><p> \"With [Johnson & Johnson] in the midst of transitions across several domains for the organization ... we see possibilities -- even within an organization of [Johnson & Johnson]'s scale and scope -- for additional potentially disruptive opportunities to develop that could reshape the investment thesis, in our view,\" he wrote.</p><p><blockquote>“随着 [强生] 正在组织的多个领域进行转型……我们看到了可能性——即使在 [强生] 规模和范围的组织内——额外的潜在颠覆性发展机会的可能性，我们认为，这可能会重塑投资论点，”他写道。</blockquote></p><p> Last month, Johnson & Johnson announced plans to spin off its sprawlingconsumer healthcare division.</p><p><blockquote>上个月，强生公司宣布计划剥离其庞大的消费者医疗保健部门。</blockquote></p><p> Shibutani's price target on Pfizer stock is $51 per share, and that for Johnson & Johnson is $161.</p><p><blockquote>涩谷对辉瑞股票的目标价为每股 51 美元，强生公司的目标价为每股 161 美元。</blockquote></p><p> Now what</p><p><blockquote>现在呢</blockquote></p><p> Pfizer and Johnson & Johnson are certainly heading into some uncertain waters -- both with the coronavirus and, in the latter company's case, the apparently looming spinoff. To my mind, though, the two companies have plenty of strength in numerous product areas outside of their respective vaccines, so investors shouldn't be too discouraged by Goldman Sachs' latest evaluations.</p><p><blockquote>辉瑞（Pfizer）和强生公司（Johnson & Johnson）无疑正进入一些不确定的水域——无论是冠状病毒，还是后者显然迫在眉睫的分拆。不过，在我看来，两家公司在各自疫苗之外的众多产品领域都拥有足够的实力，因此投资者不应对高盛的最新评估感到太气馁。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.fool.com/investing/2021/12/17/why-pfizer-and-johnson-johnson-fell-on-friday/\">Motley Fool</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","PFE":"辉瑞"},"source_url":"https://www.fool.com/investing/2021/12/17/why-pfizer-and-johnson-johnson-fell-on-friday/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1109831591","content_text":"What happened\nTwo prominent U.S. coronavirus stocks ended the week on a down note. Pfizer and Johnson & Johnson both fell on the day by nearly 3%. This followed a prominent investment bank's rather lukewarm take on their current prospects.\n\nSo what\nGoldman Sachs analyst Chris Shibutani initiated coverage on Pfizer and Johnson & Johnson on Friday, tagging both high-profile healthcare industry stocks with neutral recommendations.\nShibutani is concerned with what he considers to be Pfizer's somewhat cloudy future, despite the great success of the Comirnaty coronavirus vaccine it developed with Germanbiotech BioNTech.\n\"Our views on [Pfizer] come down to that we estimate around one-third of its current valuation is attributed to the COVID-19 vaccine and therapeutic [products], and we feel the trajectory for both remains highly uncertain,\" he wrote.\nAs for Johnson & Johnson, the prognosticator feels the stock is also fairly valued. However, he sounded a more optimistic note about the company's potential.\n\"With [Johnson & Johnson] in the midst of transitions across several domains for the organization ... we see possibilities -- even within an organization of [Johnson & Johnson]'s scale and scope -- for additional potentially disruptive opportunities to develop that could reshape the investment thesis, in our view,\" he wrote.\nLast month, Johnson & Johnson announced plans to spin off its sprawlingconsumer healthcare division.\nShibutani's price target on Pfizer stock is $51 per share, and that for Johnson & Johnson is $161.\nNow what\nPfizer and Johnson & Johnson are certainly heading into some uncertain waters -- both with the coronavirus and, in the latter company's case, the apparently looming spinoff. To my mind, though, the two companies have plenty of strength in numerous product areas outside of their respective vaccines, so investors shouldn't be too discouraged by Goldman Sachs' latest evaluations.","news_type":1,"symbols_score_info":{"PFE":0.9,"JNJ":0.9}},"isVote":1,"tweetType":1,"viewCount":4992,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699197650,"gmtCreate":1639754225279,"gmtModify":1639755324776,"author":{"id":"3582006183410147","authorId":"3582006183410147","name":"DZL","avatar":"https://static.tigerbbs.com/640ac3ae648fded99146300a53c24a5b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582006183410147","authorIdStr":"3582006183410147"},"themes":[],"title":"","htmlText":"Bank of America, American Express, U.S. Bancorp - Buffett’s stronghold with national pride ","listText":"Bank of America, American Express, U.S. Bancorp - Buffett’s stronghold with national pride ","text":"Bank of America, American Express, U.S. Bancorp - Buffett’s stronghold with national pride","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699197650","repostId":"2192497854","repostType":4,"isVote":1,"tweetType":1,"viewCount":5120,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699344792,"gmtCreate":1639752603626,"gmtModify":1639752653371,"author":{"id":"3582006183410147","authorId":"3582006183410147","name":"DZL","avatar":"https://static.tigerbbs.com/640ac3ae648fded99146300a53c24a5b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582006183410147","authorIdStr":"3582006183410147"},"themes":[],"title":"","htmlText":"Palantir and SEMrush, for those who unlock long term potential ","listText":"Palantir and SEMrush, for those who unlock long term potential ","text":"Palantir and SEMrush, for those who unlock long term potential","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/699344792","repostId":"2192635973","repostType":4,"isVote":1,"tweetType":1,"viewCount":3538,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699348856,"gmtCreate":1639752426858,"gmtModify":1639752642206,"author":{"id":"3582006183410147","authorId":"3582006183410147","name":"DZL","avatar":"https://static.tigerbbs.com/640ac3ae648fded99146300a53c24a5b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582006183410147","authorIdStr":"3582006183410147"},"themes":[],"title":"","htmlText":"Microsoft, Veeva Systems, Palo Alto Networks, tech and cloud the proven haven during correction","listText":"Microsoft, Veeva Systems, Palo Alto Networks, tech and cloud the proven haven during correction","text":"Microsoft, Veeva Systems, Palo Alto Networks, tech and cloud the proven haven during correction","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/699348856","repostId":"2192973737","repostType":4,"isVote":1,"tweetType":1,"viewCount":5798,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}